 | • レポートコード：GIR201115064 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ルフィナミドの世界市場を調査対象にし、ルフィナミドの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（錠剤、経口懸濁）、用途別分析（成人、小児患者）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Eisai、West-ward Pharms、Glenmark Pharms、Mylan ・企業別売上、市場シェア ・ルフィナミドの地域別市場分析 ・ルフィナミドの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ルフィナミドのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ルフィナミドのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ルフィナミドの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ルフィナミドの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ルフィナミドの種類別市場規模2015-2020：錠剤、経口懸濁 ・ルフィナミドの用途別市場規模2015-2020：成人、小児患者 ・ルフィナミドの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Rufinamide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Rufinamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Rufinamide market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rufinamide market has been segmented into:
Tablets
Oral suspension
By Application, Rufinamide has been segmented into:
Adults
Pediatric patients
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rufinamide market presented in the report. This section sheds light on the sales growth of different regional and country-level Rufinamide markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rufinamide market.
The report offers in-depth assessment of the growth and other aspects of the Rufinamide market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Rufinamide Market Share Analysis
Rufinamide competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rufinamide sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rufinamide sales, revenue and market share for each player covered in this report.
The major players covered in Rufinamide are:
Eisai
West-ward Pharms
Glenmark Pharms
Mylan
1 Rufinamide Market Overview
1.1 Product Overview and Scope of Rufinamide
1.2 Classification of Rufinamide by Type
1.2.1 Global Rufinamide Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Rufinamide Revenue Market Share by Type in 2019
1.2.3 Tablets
1.2.4 Oral suspension
1.3 Global Rufinamide Market by Application
1.3.1 Overview: Global Rufinamide Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Global Rufinamide Market by Regions
1.4.1 Global Rufinamide Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Rufinamide (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Rufinamide Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Rufinamide Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rufinamide Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Rufinamide Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rufinamide Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eisai
2.1.1 Eisai Details
2.1.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eisai SWOT Analysis
2.1.4 Eisai Product and Services
2.1.5 Eisai Rufinamide Revenue, Gross Margin and Market Share (2018-2019)
2.2 West-ward Pharms
2.2.1 West-ward Pharms Details
2.2.2 West-ward Pharms Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 West-ward Pharms SWOT Analysis
2.2.4 West-ward Pharms Product and Services
2.2.5 West-ward Pharms Rufinamide Revenue, Gross Margin and Market Share (2018-2019)
2.3 Glenmark Pharms
2.3.1 Glenmark Pharms Details
2.3.2 Glenmark Pharms Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Glenmark Pharms SWOT Analysis
2.3.4 Glenmark Pharms Product and Services
2.3.5 Glenmark Pharms Rufinamide Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mylan SWOT Analysis
2.4.4 Mylan Product and Services
2.4.5 Mylan Rufinamide Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Rufinamide Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Rufinamide Players Market Share
3.2.2 Top 10 Rufinamide Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Rufinamide Revenue and Market Share by Regions
4.2 North America Rufinamide Revenue and Growth Rate (2015-2020)
4.3 Europe Rufinamide Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Rufinamide Revenue and Growth Rate (2015-2020)
4.5 South America Rufinamide Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Rufinamide Revenue and Growth Rate (2015-2020)
5 North America Rufinamide Revenue by Countries
5.1 North America Rufinamide Revenue by Countries (2015-2020)
5.2 USA Rufinamide Revenue and Growth Rate (2015-2020)
5.3 Canada Rufinamide Revenue and Growth Rate (2015-2020)
5.4 Mexico Rufinamide Revenue and Growth Rate (2015-2020)
6 Europe Rufinamide Revenue by Countries
6.1 Europe Rufinamide Revenue by Countries (2015-2020)
6.2 Germany Rufinamide Revenue and Growth Rate (2015-2020)
6.3 UK Rufinamide Revenue and Growth Rate (2015-2020)
6.4 France Rufinamide Revenue and Growth Rate (2015-2020)
6.5 Russia Rufinamide Revenue and Growth Rate (2015-2020)
6.6 Italy Rufinamide Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Rufinamide Revenue by Countries
7.1 Asia-Pacific Rufinamide Revenue by Countries (2015-2020)
7.2 China Rufinamide Revenue and Growth Rate (2015-2020)
7.3 Japan Rufinamide Revenue and Growth Rate (2015-2020)
7.4 Korea Rufinamide Revenue and Growth Rate (2015-2020)
7.5 India Rufinamide Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Rufinamide Revenue and Growth Rate (2015-2020)
8 South America Rufinamide Revenue by Countries
8.1 South America Rufinamide Revenue by Countries (2015-2020)
8.2 Brazil Rufinamide Revenue and Growth Rate (2015-2020)
8.3 Argentina Rufinamide Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Rufinamide by Countries
9.1 Middle East & Africa Rufinamide Revenue by Countries (2015-2020)
9.2 Saudi Arabia Rufinamide Revenue and Growth Rate (2015-2020)
9.3 UAE Rufinamide Revenue and Growth Rate (2015-2020)
9.4 Egypt Rufinamide Revenue and Growth Rate (2015-2020)
9.5 South Africa Rufinamide Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Rufinamide Revenue and Market Share by Type (2015-2020)
10.2 Global Rufinamide Market Forecast by Type (2019-2024)
10.3 Tablets Revenue Growth Rate (2015-2025)
10.4 Oral suspension Revenue Growth Rate (2015-2025)
11 Global Rufinamide Market Segment by Application
11.1 Global Rufinamide Revenue Market Share by Application (2015-2020)
11.2 Rufinamide Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2015-2020)
11.4 Pediatric patients Revenue Growth (2015-2020)
12 Global Rufinamide Market Size Forecast (2021-2025)
12.1 Global Rufinamide Market Size Forecast (2021-2025)
12.2 Global Rufinamide Market Forecast by Regions (2021-2025)
12.3 North America Rufinamide Revenue Market Forecast (2021-2025)
12.4 Europe Rufinamide Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Rufinamide Revenue Market Forecast (2021-2025)
12.6 South America Rufinamide Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Rufinamide Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Rufinamide Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rufinamide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rufinamide Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Rufinamide Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eisai Corporate Information, Location and Competitors
Table 6. Eisai Rufinamide Major Business
Table 7. Eisai Rufinamide Total Revenue (USD Million) (2017-2018)
Table 8. Eisai SWOT Analysis
Table 9. Eisai Rufinamide Product and Solutions
Table 10. Eisai Rufinamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. West-ward Pharms Corporate Information, Location and Competitors
Table 12. West-ward Pharms Rufinamide Major Business
Table 13. West-ward Pharms Rufinamide Total Revenue (USD Million) (2018-2019)
Table 14. West-ward Pharms SWOT Analysis
Table 15. West-ward Pharms Rufinamide Product and Solutions
Table 16. West-ward Pharms Rufinamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Glenmark Pharms Corporate Information, Location and Competitors
Table 18. Glenmark Pharms Rufinamide Major Business
Table 19. Glenmark Pharms Rufinamide Total Revenue (USD Million) (2017-2018)
Table 20. Glenmark Pharms SWOT Analysis
Table 21. Glenmark Pharms Rufinamide Product and Solutions
Table 22. Glenmark Pharms Rufinamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Mylan Corporate Information, Location and Competitors
Table 24. Mylan Rufinamide Major Business
Table 25. Mylan Rufinamide Total Revenue (USD Million) (2017-2018)
Table 26. Mylan SWOT Analysis
Table 27. Mylan Rufinamide Product and Solutions
Table 28. Mylan Rufinamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Global Rufinamide Revenue (Million USD) by Players (2015-2020)
Table 30. Global Rufinamide Revenue Share by Players (2015-2020)
Table 31. Global Rufinamide Revenue (Million USD) by Regions (2015-2020)
Table 32. Global Rufinamide Revenue Market Share by Regions (2015-2020)
Table 33. North America Rufinamide Revenue by Countries (2015-2020)
Table 34. North America Rufinamide Revenue Market Share by Countries (2015-2020)
Table 35. Europe Rufinamide Revenue (Million USD) by Countries (2015-2020)
Table 36. Asia-Pacific Rufinamide Revenue (Million USD) by Countries (2015-2020)
Table 37. South America Rufinamide Revenue by Countries (2015-2020)
Table 38. South America Rufinamide Revenue Market Share by Countries (2015-2020)
Table 39. Middle East and Africa Rufinamide Revenue (Million USD) by Countries (2015-2020)
Table 40. Middle East and Africa Rufinamide Revenue Market Share by Countries (2015-2020)
Table 41. Global Rufinamide Revenue (Million USD) by Type (2015-2020)
Table 42. Global Rufinamide Revenue Share by Type (2015-2020)
Table 43. Global Rufinamide Revenue Forecast by Type (2021-2025)
Table 44. Global Rufinamide Revenue by Application (2015-2020)
Table 45. Global Rufinamide Revenue Share by Application (2015-2020)
Table 46. Global Rufinamide Revenue Forecast by Application (2021-2025)
Table 47. Global Rufinamide Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Rufinamide Picture
Figure 2. Global Rufinamide Revenue Market Share by Type in 2019
Figure 3. Tablets Picture
Figure 4. Oral suspension Picture
Figure 5. Rufinamide Revenue Market Share by Application in 2019
Figure 6. Adults Picture
Figure 7. Pediatric patients Picture
Figure 8. Global Rufinamide Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Rufinamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Rufinamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Rufinamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Rufinamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Rufinamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Rufinamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Rufinamide Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Rufinamide Revenue Market Share in 2019
Figure 17. Global Top 10 Players Rufinamide Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Rufinamide Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Rufinamide Revenue Market Share by Regions (2015-2020)
Figure 21. Global Rufinamide Revenue Market Share by Regions in 2018
Figure 22. North America Rufinamide Revenue and Growth Rate (2015-2020)
Figure 23. Europe Rufinamide Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Rufinamide Revenue and Growth Rate (2015-2020)
Figure 25. South America Rufinamide Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Rufinamide Revenue and Growth Rate (2015-2020)
Figure 27. North America Rufinamide Revenue Market Share by Countries (2015-2020)
Figure 28. North America Rufinamide Revenue Market Share by Countries in 2019
Figure 29. USA Rufinamide Revenue and Growth Rate (2015-2020)
Figure 30. Canada Rufinamide Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Rufinamide Revenue and Growth Rate (2015-2020)
Figure 32. Europe Rufinamide Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Rufinamide Revenue Market Share by Countries in 2019
Figure 34. Germany Rufinamide Revenue and Growth Rate (2015-2020)
Figure 35. UK Rufinamide Revenue and Growth Rate (2015-2020)
Figure 36. France Rufinamide Revenue and Growth Rate (2015-2020)
Figure 37. Russia Rufinamide Revenue and Growth Rate (2015-2020)
Figure 38. Italy Rufinamide Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Rufinamide Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Rufinamide Revenue Market Share by Countries in 2019
Figure 41. China Rufinamide Revenue and Growth Rate (2015-2020)
Figure 42. Japan Rufinamide Revenue and Growth Rate (2015-2020)
Figure 43. Korea Rufinamide Revenue and Growth Rate (2015-2020)
Figure 44. India Rufinamide Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Rufinamide Revenue and Growth Rate (2015-2020)
Figure 46. South America Rufinamide Revenue Market Share by Countries (2015-2020)
Figure 47. South America Rufinamide Revenue Market Share by Countries in 2019
Figure 48. Brazil Rufinamide Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Rufinamide Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Rufinamide Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Rufinamide Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Rufinamide Revenue and Growth Rate (2015-2020)
Figure 53. UAE Rufinamide Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Rufinamide Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Rufinamide Revenue and Growth Rate (2015-2020)
Figure 56. Global Rufinamide Revenue Share by Type (2015-2020)
Figure 57. Global Rufinamide Revenue Share by Type in 2019
Figure 58. Global Rufinamide Market Share Forecast by Type (2021-2025)
Figure 59. Global Tablets Revenue Growth Rate (2015-2020)
Figure 60. Global Oral suspension Revenue Growth Rate (2015-2020)
Figure 61. Global Rufinamide Revenue Share by Application (2015-2020)
Figure 62. Global Rufinamide Revenue Share by Application in 2019
Figure 63. Global Rufinamide Market Share Forecast by Application (2021-2025)
Figure 64. Global Adults Revenue Growth Rate (2015-2020)
Figure 65. Global Pediatric patients Revenue Growth Rate (2015-2020)
Figure 66. Global Rufinamide Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Rufinamide Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Rufinamide Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Rufinamide Revenue Market Forecast (2021-2025)
Figure 70. Europe Rufinamide Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Rufinamide Revenue Market Forecast (2021-2025)
Figure 72. South America Rufinamide Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Rufinamide Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
エトラビリンの世界市場 2020年 Market Overview The global Etravirine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Etravirine market report provides …- ラコサミドの世界市場 2020年 Market Overview The global Lacosamide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lacosamide market report provides …
- ロミプロスチムの世界市場 2020年 Market Overview The global Romiplostim market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Romiplostim market report provide…
- アルモダフィニルの世界市場 2020年 Market Overview The global Armodafinil market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Armodafinil market report provide…
- タダラフィル経口の世界市場 2020年 Market Overview The global Tadalafil Oral market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tadalafil Oral market report p…